CD BioGlyco is at the forefront of DEGL and is dedicated to facilitating groundbreaking research in glycobiology and drug discovery. Monovalent DEGL is one of our flagship services, and it is designed to provide researchers with unparalleled access to highly diverse glycan structures. Glycans play crucial roles in numerous biological processes, making them vital for the development of therapeutic agents and diagnostics. Our DEGL service is tailored to meet the bespoke needs of our clients, enabling the synthesis, customization, and screening of glycan libraries on a scale previously unattainable.
The construction of monovalent DEGL is a comprehensive project integrating chemical synthesis and molecular biology. Its core is to connect the glycan molecules to a unique DNA sequence to form a glycan-DNA conjugate, thereby achieving accurate encoding and rapid screening of the glycan structure. This monovalent connection method ensures the independence and activity of the glycan molecules in subsequent experiments and avoids non-specific interactions that may be caused by multivalent connections.
We use advanced techniques to gradually construct the target glycan structure. During the synthesis process, the reaction conditions are strictly controlled to ensure the correctness and purity of the glycan structure. Subsequently, the glycan molecules are made active to connect to DNA biological method.
In each construction cycle, we covalently link the activated glycan molecules to the DNA template. This step usually involves click chemistry, amidation reaction, or other selective connection strategies. A stable conjugate is formed between the glycan and the DNA by precisely controlling the reaction conditions while maintaining the biological activity of the glycan and the coding information of the DNA. In each cycle, new glycan structural units are introduced or structurally modified, and they are integrated into the library through the above-mentioned DNA encoding and ligation reactions. DEGLs with diverse structures and large scales are gradually constructed through multiple cycles of operation.
After the library is constructed, the unreacted raw materials and by-products are removed by purification techniques to obtain a high-purity glycan-DNA conjugate library. Subsequently, the library is identified and characterized by means of time-of-flight mass spectrometry (TOF-MS) to confirm the reaction completed.
Advanced analytical techniques such as mass spectrometry are utilized to confirm the quality of DEGL.
Technology: A technique for preparing and selecting DNA-encoded dynamic libraries (DEDLs)
Journal: Chemical Science
IF: 7.6
Published: 2015
Results: The authors detailed a technique for preparing and selecting DEDLs. Their library consisted of two sets of DNA-linked small molecules that dynamically exchanged through DNA hybridization. When a protein target was added, the equilibrium shifted to favor the formation of high-affinity bivalent binders. Significantly, the authors incorporated an innovative locking mechanism to halt the dynamic exchange, effectively "freezing" the equilibrium. This allowed for downstream hit isolation and subsequent decoding through PCR amplification and DNA sequencing. Their DEDL method overcame the constraints of library size, enabling the evaluation and selection of large dynamic libraries. Furthermore, this approach did not require modified or immobilized target proteins.
Fig.1 Schematic diagram of DEDL construction. (Li, et al., 2015)
At CD BioGlyco, our monovalent DEGL construction technology is a highly specialized, comprehensive, and customized service. We provide clients with high-quality glycan libraries with advanced chemical synthesis technology, precise DNA encoding and ligation strategies, and strong customized synthesis capabilities. These libraries help clients achieve breakthrough progress in the fields of glycoprotein interactions, disease mechanisms, and drug development. Please feel free to
for more details if you are interested in our monovalent DEGL construction service!Reference
Our mission is to provide comprehensive solutions for glycan research, from library design and high-throughput screening to detailed data analysis and validation.